Cerity Partners’s Procept Biorobotics PRCT Stock Holding History
Bought
Maintained
Sold
Other funds holding PRCT
Cerity Partners's PRCT Position: Q3 2026 in Review
Cerity Partners opened a new position in Procept Biorobotics (PRCT) in Q3 2026: 10,642 shares worth $194K. The stake represents ﹤0.01% of the portfolio and ranks #3087 among its holdings.
232 funds tracked by Wall St. Rank hold PRCT as of Q3 2026.
- Cerity Partners held 10,642 shares of Procept Biorobotics worth $194K as of Q3 2026.
- Procept Biorobotics was a new Cerity Partners position in Q3 2026.
- Procept Biorobotics made up ﹤0.01% of Cerity Partners's portfolio in Q3 2026, its #3087 holding.
- 232 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2026.
Based on Cerity Partners's 13F filing for Q3 2026, filed 13 Nov 2026.